Cargando…

Identify a DNA Damage Repair Gene Signature for Predicting Prognosis and Immunotherapy Response in Cervical Squamous Cell Carcinoma

The DNA damage repair (DDR) genes are increasingly gaining attention as potential therapeutic targets in cancers. In this study, we identified the DDR genes associated with the tumor mutation burden (TMB) and prognosis of cervical squamous cell carcinoma (CESC) based on The Cancer Genome Atlas (TCGA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Hong, Wu, Limei, Yu, Lijun, Yang, Yabing, Kong, Lili, Liu, Shuo, Chen, Wenhui, Li, Ruiman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967547/ https://www.ncbi.nlm.nih.gov/pubmed/35368888 http://dx.doi.org/10.1155/2022/8736575

Ejemplares similares

The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer
por: Zhao, Zidan, et al.
Publicado: (2023)

Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis
por: Jia, Bin, et al.
Publicado: (2022)

DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma
por: Wang, Xinshu, et al.
Publicado: (2022)

DNA damage repair-related gene signature for identifying the immune status and predicting the prognosis of hepatocellular carcinoma
por: Lu, Yongpan, et al.
Publicado: (2023)

DNA damage repair molecular subtype derived immune signature applicable for the prognosis and immunotherapy response prediction in colon cancer
por: Shang, Zhen, et al.
Publicado: (2023)

A DNA Damage Repair Gene Signature Associated With Immunotherapy Response and Clinical Prognosis in Clear Cell Renal Cell Carcinoma
por: Peng, Linjie, et al.
Publicado: (2022)

Construction of a DNA damage repair gene signature for predicting prognosis and immune response in breast cancer
por: Chang, Yiming, et al.
Publicado: (2023)

DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma
por: Chen, Yunfei, et al.
Publicado: (2021)

DNA Damage Repair-Related Genes Signature for Immune Infiltration and Outcome in Cervical Cancer
por: Wang, Xinghao, et al.
Publicado: (2022)

A Novel DNA Damage Repair-Related Gene Signature for Predicting Glioma Prognosis
por: Zhan, Jiaoyang, et al.
Publicado: (2021)

DNA Damage Repair in Brain Tumor Immunotherapy
por: Zhao, Shihong, et al.
Publicado: (2022)

A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer
por: Ren, Qianhe, et al.
Publicado: (2023)

A Comprehensive RNA Expression Signature for Cervical Squamous Cell Carcinoma Prognosis
por: Xiong, Jie, et al.
Publicado: (2019)

Identification of immune subtypes of cervical squamous cell carcinoma predicting prognosis and immunotherapy responses
por: Li, Yimin, et al.
Publicado: (2021)

A tumor-associated endothelial signature score model in immunotherapy and prognosis across pan-cancers
por: Chen, Shuzhao, et al.
Publicado: (2023)

Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma
por: Halle, Mari K., et al.
Publicado: (2021)

A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma
por: Yang, Qin, et al.
Publicado: (2022)

Identification and validation of prognosis-associated DNA repair gene signatures in colorectal cancer
por: Song, Dingli, et al.
Publicado: (2022)

Mutational signatures are jointly shaped by DNA damage and repair
por: Volkova, Nadezda V., et al.
Publicado: (2020)

The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma
por: Li, Xizhe, et al.
Publicado: (2022)

Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma
por: Liu, Dan, et al.
Publicado: (2021)

Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer
por: Zhao, Hongying, et al.
Publicado: (2023)

Characterization of tumor immune microenvironment and cancer therapy for head and neck squamous cell carcinoma through identification of a genomic instability-related lncRNA prognostic signature
por: Jing, Lijun, et al.
Publicado: (2022)

Identification and Validation of a Novel DNA Damage and DNA Repair Related Genes Based Signature for Colon Cancer Prognosis
por: Wang, Xue-quan, et al.
Publicado: (2021)

Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma
por: Chen, Yi, et al.
Publicado: (2022)

Prediction of immune infiltration and prognosis for patients with urothelial bladder cancer based on the DNA damage repair-related genes signature
por: Li, Tianhang, et al.
Publicado: (2023)

Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma
por: Mao, Guangxian, et al.
Publicado: (2023)

A cuproptosis-associated long non-coding RNA signature for the prognosis and immunotherapy of lung squamous cell carcinoma
por: Hou, Chunlan, et al.
Publicado: (2023)

Leveraging Tumor Microenvironment Infiltration in Pancreatic Cancer to Identify Gene Signatures Related to Prognosis and Immunotherapy Response
por: Yang, Jiabin, et al.
Publicado: (2023)

DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma
por: Liang, Liping, et al.
Publicado: (2022)

A novel neutrophil extracellular trap signature to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma
por: Li, Qilin, et al.
Publicado: (2022)

Development of an endoplasmic reticulum stress-related signature with potential implications in prognosis and immunotherapy in head and neck squamous cell carcinoma
por: Fan, Xinlong, et al.
Publicado: (2023)

A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma
por: Zhang, Dengfeng, et al.
Publicado: (2023)

m(7)G-Related DNA Damage Repair Genes are Potential Biomarkers for Predicting Prognosis and Immunotherapy Effectiveness in Colon Cancer Patients
por: Chen, Shuran, et al.
Publicado: (2022)

Characterization of the Tumor Microenvironment in Osteosarcoma Identifies Prognostic- and Immunotherapy-Relevant Gene Signatures
por: Tan, Jianye, et al.
Publicado: (2022)

Advances of DNA Damage Repair-Related Drugs and Combination With Immunotherapy in Tumor Treatment
por: Wang, Yumin, et al.
Publicado: (2022)

Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer
por: Yu, Sihui, et al.
Publicado: (2021)

Comprehensive analysis identifies DNA damage repair-related gene HCLS1 associated with good prognosis in lung adenocarcinoma
por: Liu, Tingjun, et al.
Publicado: (2023)

Transcriptomic and Metabolomic Profiling in Helicobacter pylori–Induced Gastric Cancer Identified Prognosis- and Immunotherapy-Relevant Gene Signatures
por: Liu, Duanrui, et al.
Publicado: (2021)

Evaluating the utility of an immune checkpoint-related lncRNA signature for identifying the prognosis and immunotherapy response of lung adenocarcinoma
por: Zhang, Hongpan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1vkott1icuc5q9ouonbmhrrc4a